PRAK is essential for ras-induced senescence and tumor suppression - PubMed (original) (raw)
. 2007 Jan 26;128(2):295-308.
doi: 10.1016/j.cell.2006.11.050.
Naoto Yoshizuka, Liguo New, Bettina A Moser, Yilei Li, Rong Liao, Changchuan Xie, Jianming Chen, Qingdong Deng, Maria Yamout, Meng-Qiu Dong, Costas G Frangou, John R Yates 3rd, Peter E Wright, Jiahuai Han
Affiliations
- PMID: 17254968
- DOI: 10.1016/j.cell.2006.11.050
Free article
PRAK is essential for ras-induced senescence and tumor suppression
Peiqing Sun et al. Cell. 2007.
Free article
Abstract
Like apoptosis, oncogene-induced senescence is a barrier to tumor development. However, relatively little is known about the signaling pathways mediating the senescence response. p38-regulated/activated protein kinase (PRAK) is a p38 MAPK substrate whose physiological functions are poorly understood. Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras. PRAK deficiency in mice enhances DMBA-induced skin carcinogenesis, coinciding with compromised senescence induction. In primary cells, inactivation of PRAK prevents senescence and promotes oncogenic transformation. Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression.
Comment in
- Oncogene-induced senescence pathways weave an intricate tapestry.
Yaswen P, Campisi J. Yaswen P, et al. Cell. 2007 Jan 26;128(2):233-4. doi: 10.1016/j.cell.2007.01.005. Cell. 2007. PMID: 17254959 Review.
Similar articles
- Oncogene-induced senescence pathways weave an intricate tapestry.
Yaswen P, Campisi J. Yaswen P, et al. Cell. 2007 Jan 26;128(2):233-4. doi: 10.1016/j.cell.2007.01.005. Cell. 2007. PMID: 17254959 Review. - A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence.
Zheng H, Seit-Nebi A, Han X, Aslanian A, Tat J, Liao R, Yates JR 3rd, Sun P. Zheng H, et al. Mol Cell. 2013 Jun 6;50(5):699-710. doi: 10.1016/j.molcel.2013.04.013. Epub 2013 May 16. Mol Cell. 2013. PMID: 23685072 Free PMC article. - Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK.
Ronkina N, Johansen C, Bohlmann L, Lafera J, Menon MB, Tiedje C, Laaß K, Turk BE, Iversen L, Kotlyarov A, Gaestel M. Ronkina N, et al. PLoS One. 2015 Aug 21;10(8):e0136138. doi: 10.1371/journal.pone.0136138. eCollection 2015. PLoS One. 2015. PMID: 26295581 Free PMC article. - PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.
Yoshizuka N, Lai M, Liao R, Cook R, Xiao C, Han J, Sun P. Yoshizuka N, et al. Mol Cancer Res. 2012 Jun;10(6):810-20. doi: 10.1158/1541-7786.MCR-11-0576. Epub 2012 Jun 4. Mol Cancer Res. 2012. PMID: 22665523 Free PMC article. - The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
Barnoud T, Schmidt ML, Donninger H, Clark GJ. Barnoud T, et al. Cancer Lett. 2017 Aug 1;400:30-36. doi: 10.1016/j.canlet.2017.04.030. Epub 2017 Apr 26. Cancer Lett. 2017. PMID: 28455242 Free PMC article. Review.
Cited by
- Induction of p38δ expression plays an essential role in oncogenic ras-induced senescence.
Kwong J, Chen M, Lv D, Luo N, Su W, Xiang R, Sun P. Kwong J, et al. Mol Cell Biol. 2013 Oct;33(19):3780-94. doi: 10.1128/MCB.00784-13. Epub 2013 Jul 22. Mol Cell Biol. 2013. PMID: 23878395 Free PMC article. - Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis.
Wiley CD, Sharma R, Davis SS, Lopez-Dominguez JA, Mitchell KP, Wiley S, Alimirah F, Kim DE, Payne T, Rosko A, Aimontche E, Deshpande SM, Neri F, Kuehnemann C, Demaria M, Ramanathan A, Campisi J. Wiley CD, et al. Cell Metab. 2021 Jun 1;33(6):1124-1136.e5. doi: 10.1016/j.cmet.2021.03.008. Epub 2021 Apr 2. Cell Metab. 2021. PMID: 33811820 Free PMC article. - MK2 Regulates Ras Oncogenesis through Stimulating ROS Production.
Kobayashi Y, Qi X, Chen G. Kobayashi Y, et al. Genes Cancer. 2012 Jul;3(7-8):521-30. doi: 10.1177/1947601912462718. Genes Cancer. 2012. PMID: 23264852 Free PMC article. - Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy.
Zou J, Ma Q, Sun R, Cai J, Liao H, Xu L, Xia J, Huang G, Yao L, Cai Y, Zhong X, Guo X. Zou J, et al. BMB Rep. 2019 Aug;52(8):520-524. doi: 10.5483/BMBRep.2019.52.8.058. BMB Rep. 2019. PMID: 31383247 Free PMC article. - Network pharmacology and molecular docking to elucidate the mechanism of pulsatilla decoction in the treatment of colon cancer.
Liu H, Hu Y, Qi B, Yan C, Wang L, Zhang Y, Chen L. Liu H, et al. Front Pharmacol. 2022 Aug 8;13:940508. doi: 10.3389/fphar.2022.940508. eCollection 2022. Front Pharmacol. 2022. PMID: 36003525 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI041637/AI/NIAID NIH HHS/United States
- AI054696/AI/NIAID NIH HHS/United States
- CA106768/CA/NCI NIH HHS/United States
- CA91922/CA/NCI NIH HHS/United States
- GM67101/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous